Addition of Metformin to Concurrent Chemoradiation in Patients With Locally Advanced Non–Small Cell Lung Cancer

Overview of attention for article published in JAMA Oncology, September 2021

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (97th percentile)
High Attention Score compared to outputs of the same age and source (83rd percentile)

So far, Altmetric has seen 8 news stories from 7 outlets.

Although well tolerated, metformin does not improve survival when given alongside chemoradiotherapy to patients with locally…

Although well tolerated, metformin does not improve survival when given alongside chemoradiotherapy to patients with locally…

A combination of metformin and chemoradiation in patients with locally advanced non-small cell lung cancer (LA-NSCLC) was not…

Credit: Pixabay/CC0 Public Domain A combination of metformin and chemoradiation in patients with locally advanced non-small…

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity, including 4 additional news stories.